单位：[1]Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital Institute of Respiratory Medicine, Chinese Academy of Medical Sciences National Clinical Research Center for Respiratory Diseases, Beijing 100029, China.
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81270117]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2018-I2M-1-003]
第一作者单位：[1]Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital Institute of Respiratory Medicine, Chinese Academy of Medical Sciences National Clinical Research Center for Respiratory Diseases, Beijing 100029, China.
通讯作者：
通讯机构：[1]Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital Institute of Respiratory Medicine, Chinese Academy of Medical Sciences National Clinical Research Center for Respiratory Diseases, Beijing 100029, China.[*1]Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital Institute of Respiratory Medicine, Chinese Academy of Medical Sciences National Clinical Research Center for Respiratory Diseases, Beijing 100029, China
推荐引用方式(GB/T 7714)：
Liu Zhi-Bo,Xie Wan-Mu,Zhai Zhen-Guo,et al.Pulmonary aspergillosis with in-situ pulmonary artery thrombosis: to anti-coagulate or not?[J].CHINESE MEDICAL JOURNAL.2019,132(14):1742-1744.doi:10.1097/CM9.0000000000000336.
APA：
Liu, Zhi-Bo,Xie, Wan-Mu,Zhai, Zhen-Guo,Cao, Bin&Wan, Jun.(2019).Pulmonary aspergillosis with in-situ pulmonary artery thrombosis: to anti-coagulate or not?.CHINESE MEDICAL JOURNAL,132,(14)
MLA：
Liu, Zhi-Bo,et al."Pulmonary aspergillosis with in-situ pulmonary artery thrombosis: to anti-coagulate or not?".CHINESE MEDICAL JOURNAL 132..14(2019):1742-1744
